Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Research

March 21, 2017 – Our skin is covered in a web of billions of tiny organisms including bacteria, viruses and fungi. This web is called the skin microbiome and when healthy, helps our bodies function properly inside and out. Researchers have long known that people with atopic dermatitis (AD) have different skin biology than those […]

Read More


October 18, 2016 – For the first time in decades, new drugs and therapies that may provide real relief for anyone living with eczema are close to being available. For many, this is a time of unprecedented hope. But what if there were a way to prevent the very first flare, to stop eczema from even starting? Frustrated by […]

Read More


October 4, 2016 — A recent survey conducted by the National Eczema Association (NEA) in early September revealed at more than 20% of parents and caregivers who responded indicated their children experienced bullying at school, during extracurricular activities or with friends because of eczema. The Dermatology Times highlighted this difficult problem in a recent article, […]

Read More


PRESS RELEASE One in five children with eczema will be bullied this school year due to their disease, according to the National Eczema Association San Rafael, California, September 7, 2016 – Results from a new National Eczema Association (NEA) survey of eczema parents and caregivers show that at least one in five children with eczema, including […]

Read More


Understanding AD’s impact to improve your quality of life July 19, 2016 — People living with atopic dermatitis (AD), the most common and chronic form of eczema, know first-hand the burden AD has on both individuals and families. The impacts reach far beyond the serious effects of the disease symptoms such as itch, pain, and […]

Read More


We asked, you answered. The verdict? People living with eczema want more information and more options. This past January, many of you responded to a 6-question online survey to evaluate patient satisfaction and the role of doctors in the treatment of the most serious form of eczema, atopic dermatitis (AD). We learned that the vast majority of […]

Read More


June 9, 2016 – On Monday, June 6, 2016 the pharmaceutical companies Regeneron and Sanofi, reported positive results for the Phase 3 the clinical trial of the new biologic drug, dupilumab, when used in conjunction with a topical corticosteroid by adults to treat moderate-to-severe atopic dermatitis (AD).

Read More


We all play an important role, especially patients, in bringing new treatments to those that need them. Research is like a relay race that scientists can only take so far, and at some point, they must hand the baton to patients to engage in clinical trials to help bring the treatment to reality. The National […]

Read More


Increasingly, the concept of leaky gut is being touted by alternative and holistic practitioners as being fundamentally important in many chronic illnesses. By Peter A. Lio and Karan Lal, MS-4 It is now well accepted that skin barrier dysfunction is implicated in a variety of important inflammatory skin diseases including acne, atopic dermatitis, and psoriasis.1 […]

Read More


NEA formed a Scientific Advisory Committee Task Force to conduct a systematic review of topical corticosteroid withdrawal/topical steroid addiction in patients with atopic dermatitis and other dermatoses, and created a NEA education announcement on Topical Steroid Addiction/Withdrawal.

Read More